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Vitamin E is the collective term given to a group of fat-soluble compounds first discovered in 1922 by Evans and Bishop; 
these compounds have distinct antioxidant activities 
essential for health.1 Vitamin E is present in fat-
containing foods2 and, as the fat-soluble property of the 
vitamin allows it to be stored within the fatty tissues of 
animals and humans, it does not have to be consumed 
every day. The vitamin E group (i.e. chroman-6-ols), 
collectively termed tocochromanols (divided into 
tocopherols and tocotrienols), includes all of the tocol 
and tocotrienol derivatives which qualitatively exhibit 
the biological activity of d-alpha-tocopherol.
There are eight naturally occurring forms of 
vitamin E; namely, the alpha, beta, gamma and delta 
classes of tocopherol and tocotrienol, which are 
synthesised by plants from homogentisic acid. Alpha- 
and gamma-tocopherols are the two major forms of 
the vitamin, with the relative proportions of these 
depending on the source. The richest dietary sources 
of vitamin E are edible vegetable oils as they contain 
all the different homologues in varying proportions 
[Table 1]. Among the tocopherols, the alpha- and 
gamma-tocopherols are found in the serum and the 
red blood cells, with alpha-tocopherol present in the 
highest concentration.3 Beta- and delta-tocopherols 
are found in the plasma in minute concentrations only. 
The preferential distribution of alpha-tocopherol in 
humans over the other forms of tocopherol stems from 
the faster metabolism of the other forms and from 
the alpha-tocopherol transfer protein (alpha-TTP). It 
is due to the binding affinity of alpha-tocopherol with 
alpha-TTP that most of the absorbed beta-, gamma- 
and delta-tocopherols are secreted into the bile and 
excreted in the faeces, while alpha-tocopherol is largely 
excreted in the urine. The alpha-tocopherol form also 
accumulates in the non-hepatic tissues, particularly 
at sites where free radical production is greatest, 
such as in the membranes of the mitochondria and 
endoplasmic reticulum in the heart and lungs. 
This review mainly focuses on the current 
developments in vitamin E research in the context 
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abstract: Vitamin E is the major lipid-soluble component in the cell antioxidant defence system and is 
exclusively obtained from the diet. It has numerous important roles within the body because of its antioxidant 
activity. Oxidation has been linked to numerous possible conditions and diseases, including cancer, ageing, 
arthritis and cataracts; vitamin E has been shown to be effective against these. Platelet hyperaggregation, which 
can lead to atherosclerosis, may also be prevented by vitamin E; additionally, it also helps to reduce the production 
of prostaglandins such as thromboxane, which cause platelet clumping. The current literature review discusses 
the functions and roles of vitamin E in human health and some diseases as well as the consequences of vitamin E 
deficiency. The main focus of the review is on the tocopherol class of the vitamers.
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امللخ�ص: يعد فيتامني هـ املكون الرئي�صي  الذائب يف الدهن يف اجلهاز الدفاعي امل�صاد للأك�صدة. يتح�صل الب�رش على هذا الفيتامني ب�صورة كاملة من 
الغذاء. للفيتامني وظائف مهمة عديدة يف داخل اجل�صم لكونه م�صادا للأك�صدة. ترتبط الأك�صدة بعدد من احلالت والأمرا�س مثل ال�رشطان والهرم والتهابات 
املفا�صل وال�صاد )كاتراكت(، و لفيتامني هـ فعالية �صد جميع هذه الأمرا�س واحلالت. مينع تناول فيتامني هـ التجلط املفرط لل�صفائح الدموية، والذي 
قد يوؤدي اإىل الت�صلب الع�صيدي، ويقوم اأي�صا الفيتامني بتقليل انتاج الربو�صتاغلدين مثل الرثومبوك�صني والذي ي�صبب تكد�س ال�صفائح الدموية. يناق�س 
هذا املقال ال�صتعرا�صي وظائف واأدوار فيتامني هـ  يف حالتي ال�صحة واملر�س، والنتائج املرتتبة على نق�س الفيتامني. يركز املقال عن هذا الفيتامني 
على التوكوفريول
مفتاح الكلمات: فيتامني هـ؛ ال�صحة؛ التوكوفريول؛ م�صادات الأك�صدة. 
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of their importance to human health and disease 
prevention. The data obtained from a survey of clinical 
trials or systematic reviews have been included here 
due to the difficulty of proving the efficacy of vitamin 
E supplementation, and in order to describe the 
evidence-based results.
Chemistry of Vitamin E
The term ‘tocopherol’ signifies the methyl-substituted 
derivatives of tocol and is not synonymous with the 
term ‘vitamin E’. Natural tocochromanols comprise 
two homologous series: tocopherols with a saturated 
side chain and tocotrienols with an unsaturated side 
chain. Tocopherols and tocotrienols have the same 
basic chemical structure, which is characterised by a 
long isoprenoid side chain attached at the 2 position of 
a 6-chromanol ring, as shown in Figure 1. 
Tocotrienols differ from tocopherols in that they 
possess a farnesyl rather than a saturated isoprenoid 
C16 side chain. Natural tocopherols occur in the 
RRR-configuration while the synthetic form contains 
eight different stereoisomers and is called all-rac-
alpha-tocopherol. Tocotrienols possess only the 
chiral stereocenter at C-2 and naturally occurring 
tocotrienols exclusively possess the 2R,3’E,7’E 
configuration.5 The receptors and enzymes in the 
body are highly stereoselective and interact exclusively 
with one of the enantiomers of a chiral molecule in a 
process called chiral recognition. As a result, only one 
enantiomer has the desired effect on the body, while 
the others may have either no effect or an adverse 
effect.6 Vitamin E isoforms are not interconvertible 
inside the human body.7
Sources and Recommended 
Intakes 
Vitamin E is found in various foods and oils. Nuts, 
seeds and vegetable oils contain high amounts of 
alpha-tocopherol, and significant amounts are also 
available in green leafy vegetables and fortified cereals. 
Some of the richest sources of vitamin E, along with 
their tocopherol content and percent daily values, are 
shown in Tables 1 and 2.
No specific recommendations regarding the intake 
of vitamin E have been made officially, and the optimal 
supplementation dosage of mixed tocopherols is still 
undetermined. When obtained from food sources 
alone, vitamin E has no documented evidence of 
toxicity. However, evidence of pro-oxidant damage 
has been found to be associated with supplements, but 
usually only at very high doses (for example at >1,000 
mg/day).9 The recommended dietary allowances 
(RDAs) for vitamin E (alpha-tocopherol) are shown in 
Table 3.









in mg of tocopherol per 100 g
Coconut 0.5 0 0.6 0.5
Maize 
(corn)
11.2 60.2 1.8 0
Palm 25.6 31.6 7.0 14.3
Olive 5.1 Trace 
amounts
0 0
Peanut 13.0 21.4 2.1 0
Soybean 10.1 59.3 26.4 0
Wheatgerm 133.0 26.0 27.1 2.6
Sunflower 48.7 5.1 0.8 0
Source: Slover HT. Tocopherols in foods and fats.4
Table 2: Selected dietary sources of vitamin E (alpha-
tocopherol)










Wheat germ oil, 1 tablespoon 20.3 100
Sunflower seeds, dry roasted, 
1 ounce
7.4 37
Almonds, dry roasted, 1 
ounce
6.8 34
Sunflower oil, 1 tablespoon 5.6 28
Safflower oil, 1 tablespoon 4.6 25
Hazelnuts, dry roasted, 1 
ounce
4.3 22
Peanut butter, 2 tablespoons 2.9 15
Peanuts, dry roasted, 1 ounce 2.2 11
Corn oil, 1 tablespoon 1.9 10
Spinach, boiled, ½ cup 1.9 10
Broccoli, chopped, boiled, 
½ cup
1.2 6
Soybean oil, 1 tablespoon 1.1 6
Kiwifruit, 1 medium 1.1 6
Mango, sliced, ½ cup 0.7 4
Tomato, raw, 1 medium 0.7 4
Spinach, raw, 1 cup 0.6 3
Adapted from: United States Department of Agriculture (USDA), 
Agricultural Research Service. USDA National Nutrient Database for 
Standard Reference, Release 25.8
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vitamin E supplements in humans were also seen to 
increase the under-carboxylation of prothrombin,13 
suggesting that vitamin E decreases the vitamin K 
status in humans.
Functions of Vitamin E 
prevention of oxidative stress
Vitamin E is a potent chain-breaking antioxidant that 
inhibits the production of reactive oxygen species 
molecules when fat undergoes oxidation and during the 
propagation of free radical reactions.14 It is primarily 
located in the cell and organelle membranes where it 
can exert its maximum protective effect, even when 
its concentration ratio may be only one molecule for 
every 2,000 phospholipid molecules. It acts as the first 
line of defence against lipid peroxidation, protecting 
the cell membranes from free radical attack [Figure 
2]. Studies have shown that a  mixture of tocopherols 
has a stronger inhibitory effect on lipid peroxidation 
induced in human erythrocytes compared to alpha-
tocopherol alone.15 Due to its peroxyl radical-
scavenging activity, it also protects the polyunsaturated 
fatty acids present in membrane phospholipids and 
in plasma lipoproteins.16 The tocopheroxyl radicals 
formed can either: (1) oxidise other lipids; (2) undergo 
further oxidation producing tocopheryl quinones; (3) 
form non-reactive tocopherol dimers by reacting with 
another tocopheroxyl radical, or (4) be reduced by 
other antioxidants to tocopherol.
It has been found that alpha-tocopherol mainly 
inhibits the production of new free radicals, while 
gamma-tocopherol traps and neutralises the existing 
free radicals. Oxidation has been linked to numerous 
possible conditions/diseases including: cancer, ageing, 
arthritis and cataracts. Thus, vitamin E might help 
prevent or delay the chronic diseases associated with 
Interactions with Dietary 
Factors
Vitamin E is heavily dependent on vitamin C, vitamin 
B3, selenium and glutathione. A diet high in vitamin E 
cannot have an optimal effect unless it is also rich in 
foods that provide these other nutrients. It was found 
that a cooperative interaction between vitamin C and 
vitamin E is quite probable, while one between vitamin 
C and beta-carotene is improbable and one may exist 
between vitamin E and beta-carotene.10 Interactions 
were also found between thiols, tocopherols and other 
compounds which enhance the effectiveness of the 
cellular antioxidant defence systems.11 
In 2007, reports from the Women’s Health Study 
(WHS) demonstrated that vitamin E supplements 
decrease the risk of mortality from thromboembolism 
and that alpha-tocopherol decreases the tendency 
for clotting in normal healthy women.12 In addition, 
Table 3: Recommended dietary allowances for vitamin 
E (alpha-tocopherol)
Age RDA in mg (IU)
Males Females
0–6 months* 4 (6) 4 (6)
7–12 months* 5 (7.5) 5 (7.5)
1–3 years 6 (9) 6 (9)
4–8 years 7 (10.4) 7 (10.4)






15 (22.4) 15 (22.4)
15 (22.4)
19 (28.4)
RDA = recommended dietary allowances; IU = international units.
*Adequate intake.
Source: Institute of Medicine. Food and Nutrition Board. Dietary 
Reference Intakes: Vitamin C, Vitamin E, Selenium, and Carotenoids.63
Figure 1: The structures of a tocopherol and tocotrienol.
Adapted from: Colombo ML. An update on vitamin E, tocopherol and tocotrienol: Perspectives.10
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reactive oxygen species molecules.
protection of the cell 
membranes
Vitamin E increases the orderliness of the membrane 
lipid packaging, thus allowing for a tighter packing 
of the membrane and, in turn, greater stability to 
the cell. In 2011, Howard et al. showed that vitamin 
E is necessary for maintaining proper skeletal muscle 
homeostasis and that the supplementation of cultured 
myocytes with alpha-tocopherol promotes plasma 
membrane repair.18 This occurs because the membrane 
phospholipids are prominent targets of oxidants and 
vitamin E efficiently prevents lipid peroxidation. 
Conversely, in the absence of alpha-tocopherol 
supplementation, the exposure of the cultured cells 
to an oxidant challenge strikingly inhibits the repair. 
Comparative measurements reveal that in order to 
promote the repair, an antioxidant must associate 
with the membranes, as alpha-tocopherol does, or 
be capable of alpha-tocopherol regeneration. Thus, 
vitamin E promotes membrane repair by preventing the 
formation of oxidised phospholipids that theoretically 
might interfere with the membrane fusion events.
regulation of platelet 
aggregation and protein kinase 
c activation
An increase in the concentration of alpha-tocopherol 
in the endothelial cells has been found to inhibit platelet 
aggregation and to release prostacyclin from the 
endothelium. This effect was thought to occur because 
of the downregulation of the intracellular cell adhesion 
molecule (ICAM-1) and the vascular cell adhesion 
molecule (VCAM-1), thereby decreasing the adhesion 
of blood cell components to the endothelium. Also, due 
to their upregulation by vitamin E in the arachidonic 
acid cascade, the increase in the expression of cytosolic 
phospholipase A2,19 and cyclooxygenase-1,20 increases 
the release of prostacyclin, which is a potent vasodilator 
and inhibitor of platelet aggregation in humans.21 A 
few other studies suggest that tocopherols appear to 
inhibit platelet aggregation through the inhibition of 
protein kinase C (PKC)22 and the increased action of 
nitric oxide synthase.23
The natural RRR-configuration form of alpha-
tocopherol has been shown to be twice as potent as 
the other all-racemic (synthetic) alpha-tocopherols 
in inhibiting PKC activity.24 This occurs because of 
the attenuating effect of alpha-tocopherol on the 
generation of membrane-derived diacylglycerol (a lipid 
which facilitates PKC translocation and thus increases 
its activity); additionally, alpha-tocopherol increases 
the activity of protein phosphatase type 2A, which 
inhibits PKC autophosphorylation and, consequently, 
its activity. Mixed tocopherols are more effective than 
alpha-tocopherol in inhibiting platelet aggregation. 
Adenosine diphosphate-induced platelet aggregation 
decreased significantly in healthy people who were 
given gamma-tocopherol-enriched vitamin E (100 mg 
of gamma-tocopherol, 40 mg of delta-tocopherol and 
20 mg of alpha-tocopherol per day), but not in those 
receiving pure alpha-tocopherol alone (100 mg per 
day) or in the controls.25
Vitamin E in Disease 
Prevention
Vitamin E has been found to be very effective in 
Figure 2: The mechanism of vitamin E (alpha-tocopherol)-mediated low-density lipoprotein lipid peroxidation.
Adapted from: Rathore GS, Suthar M, Pareek A, Gupta RN. Nutritional antioxidants: A battle for better health.17
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delta-tocopherol has shown growth inhibitory activity 
against mouse mammary cancer cell lines.33
Gamma-tocopherol inhibits the growth of cancer 
cells in cultures through a number of mechanisms. 
It traps free radicals, including the reactive nitrogen 
species molecules that cause mutations in the 
deoxyribonucleic acid strands and malignant 
transformations in the cells.34 It also downregulates 
the control molecules known as cyclins, stopping the 
cancerous cell cycle in the middle and thus preventing 
their proliferation.35 Gamma-tocopherol has also been 
found to be superior to alpha-tocopherol in: inducing 
apoptosis; triggering a number of cell-death-inducing 
pathways;36 stimulating peroxisome proliferator-
activated receptor gamma activity, especially in colon 
cancer cells,37 and in reducing the formation of new 
blood vessels in tumours, thus depriving them of 
the nutrients they need to thrive.38 In this context, 
tocotrienols were also found to have antiproliferative 
and apoptotic activities on normal and cancerous 
cells in humans, which could be due to the induction 
of apoptosis by a mitochondria-mediated pathway, 
or due to the suppression of cyclin D which would 
therefore arrest the cell cycle.39 They also inhibit 
vascularisation and suppress 3-hydroxy-3-methyl 
coenzyme A (HMG-CoA) reductase activity, thus 
preventing malignant proliferation.
Jiang et al. showed that, of the various forms 
of vitamin E, gamma-tocopherol, particularly in 
combination with delta-tocopherol, induced apoptosis 
in androgen-sensitive prostate cancer cells within 
three days of treatment, while alpha-tocopherol alone 
did not have the same effect.40 The gamma and delta 
E fractions appear to induce apoptosis by interrupting 
the synthesis of sphingolipid in the membranes of 
human prostate cancer cells.40 The fractions do this by 
inducing the release of cytochrome c, the activation 
of caspase-9 and caspase-3, the cleavage of poly-
adenosine diphosphate (ADP)-ribose polymerase 
(PARP) and the involvement of caspase-independent 
pathways. Recently, Chen reported that, of the 
tocopherols tested, the gamma form was the most 
potent anti-cancer form of the vitamin. They also 
found a novel anti-cancer mechanism of vitamin E: 
gamma-tocopherol, they created a new agent which 
was found to be 20-fold more effective. They did so by 
removing a string of chemical groups dangling from 
the head group of gamma-tocopherol which enhanced 
its anti-cancer effect. Chen et al. said that gamma-
tocopherol was more effective than other tocopherols 
because of its chemical structure which is more 
effective in attaching and thus shutting off the Akt 
enzyme.38 These findings suggest that an agent based 
on the chemical structure of one form of vitamin E 
the prevention and reversal of various disease 
complications due to its function as an antioxidant, 
its role in anti-inflammatory processes, its inhibition 
of platelet aggregation and its immune-enhancing 
activity. 
cardiovascular diseases
Cardiovascular complications basically arise because 
of the oxidation of low-density lipoproteins present in 
the body and the consequent inflammation.26 Gamma-
tocopherol is found to improve cardiovascular 
functions by increasing the activity of nitric oxide 
synthase, which produces vessel-relaxing nitric 
oxide.27 It does this by trapping the reactive nitrogen 
species (peroxynitriten) molecules and thus enhancing 
the endothelial function. Researchers have found that 
the supplementation of 100 mg per day of gamma-
tocopherol in humans leads to a reduction in several 
risk factors for arterial clotting, such as platelet 
aggregation and cholesterol.28 In another study, mixed 
tocopherols were found to have a stronger inhibitory 
effect on lipid peroxidation and the inhibition 
of human platelet aggregation than individual 
tocopherols alone,25 suggesting a synergistic platelet-
inhibitory effect. Apart from tocopherols, tocotrienols 
were also found to inhibit cholesterol biosynthesis by 
suppressing 3-hydroxy-3-methylglutaryl-CoA (HMG-
CoA) reductase, resulting in less cholesterol being 
manufactured by the liver cells.29 Contradictory to this, 
most of the recent large interventional clinical trials 
have not shown cardiovascular benefits from vitamin 
E supplementation and report that the use of vitamin 
E was associated with a significantly increased risk of 
a haemorrhagic stroke in the participants.30 Thus, it 
was suggested that understanding the potential uses of 
vitamin E in preventing coronary heart disease might 
require longer studies with younger participants.  
cancer
Vitamin E also possesses anti-cancer properties. This 
is possibly because of the various functions of vitamin 
E which include: the stimulation of the wild-type p53 
tumor suppressor gene; the downregulation of mutant 
p53 proteins; the activation of heat shock proteins, and 
an anti-angiogenic effect mediated by the blockage of 
transforming growth factor alpha.31 Alpha-, gamma- 
and delta-tocopherols have emerged as vitamin E 
molecules with functions clearly distinct from each 
other in anti-cancer activity as well. Alpha-tocopherol 
was found to inhibit the production of PKC and 
collagenase,32 which facilitate cancer cell growth. In 
this context gamma-tocopherol was found to be more 
effective than alpha-tocopherol in its growth inhibitory 
effect on human prostate cancer cell lines, whereas 
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could help to prevent and treat numerous types of 
cancer—particularly those associated with a mutation 
in the PTEN gene, a fairly common cancer-related 
genetic defect that keeps protein kinase B (Akt) active. 
Chen studied both alpha and gamma forms of the 
vitamin E molecule; both inhibited the Akt enzyme in 
very targeted ways, but the gamma structure emerged 
as the more powerful form of the vitamin. In effect, 
the vitamin halted Akt activation by attracting Akt 
and the PHLPP1 protein to the same region of a cell 
where the vitamin was absorbed in the fat-rich cell 
membrane. The PHLPP1 tumour suppressor protein 
then launched a chemical reaction that inactivated 
Akt, rendering it unable to keep cancer cells alive.
Apart from these findings, the role of vitamin 
E in cancer prevention remains controversial. The 
reports from the Cancer Institute of New Jersey 
show that gamma- and delta-tocopherols can prevent 
colon, lung, breast and prostate cancers, while alpha-
tocopherol had no such effect. In addition, human 
trials and surveys aiming to study the association 
between vitamin E intake and cancer have found 
that vitamin E is not beneficial in most cases. Both 
the Heart Outcomes Prevention Evaluation—The 
Ongoing Outcomes (HOPE-TOO) trial and the WHS 
study evaluated whether vitamin E supplements might 
protect people from cancer and found no significant 
reduction in the risk of developing cancer in individuals 
taking daily doses of 400 IU or 600 IU of vitamin E.41,42
cataracts
Cataracts are one of the commonest causes of significant 
vision loss in older people. They basically occur due 
to the accumulation of proteins damaged by free 
radicals. Several observational studies have revealed a 
potential relationship between vitamin E supplements 
and the risk of cataract formation. Leske et al. found 
that lens clarity was superior in participants who took 
vitamin E supplements and those with higher blood 
levels of the vitamin.43 In another study, a long-term 
supplementation of vitamin E was associated with the 
slower progression of age-related lens opacification.44 
However, in the randomised Age-Related Eye Disease 
Study (AREDS), vitamin E had no apparent effect on 
cataract development/progression over an average 
of 6.3 years.45 Overall, the available evidence is 
insufficient to conclude that vitamin E supplements, 
taken alone or in combination with other antioxidants, 
can reduce the risk of cataract formation.
alzheimer’s disease 
Alzheimer’s disease (AD) occurs as a result of protein 
oxidation and lipid peroxidation via a free radical 
mechanism, where the beta amyloid protein induces 
cytotoxicity through a mechanism involving oxidative 
stress and hydrogen peroxide, leading to neuronal 
cell death and, finally, AD. Vitamin E can block the 
production of hydrogen peroxide and the resulting 
cytotoxicity. It reduces beta amyloid-induced cell death 
in rat hippocampal cell cultures46 and PC12 cells47 and 
attenuates the excitatory amino acid-induced toxicity 
in neuroblastoma cells.48 The Alzheimer’s Disease 
Cooperative Study in 1997 showed that vitamin E may 
slow disease progression in patients with moderately 
severe AD. High doses of vitamin E delayed the loss 
of the patient’s ability to carry out daily activities 
and their consequent placement in residential care 
for several months.49 In another study, it was found 
that subjects with AD had reduced concentrations 
of plasma antioxidant micronutrients, suggesting 
that inadequate antioxidant activity is a factor in this 
disease. High plasma levels of vitamin E are associated 
with a reduced risk of AD in older patients and this 
neuroprotective effect is related to the combination 
of different forms of vitamin E rather than to alpha-
tocopherol alone.50 A study published in 2009 examined 
the effects of taking 2,000 IU of vitamin E with and 
without an AD drug on 847 people. It concluded that 
vitamin E plus a cholinesterase inhibitor may be more 
beneficial than taking either agent alone.51 
At the biomarker level, Mangialasche et al. 
demonstrated that plasma levels of tocopherols and 
tocotrienols together with automated magnetic 
resonance imaging (MRI) measures can help to 
differentiate patients with AD and mild cognitive 
impairment (MCI) from the control subjects, and 
prospectively predict the MCI conversion into AD.49 
This therefore suggests the potential role of nutritional 
biomarkers detected in plasma-tocopherols and 
tocotrienols as indirect indicators of AD pathology.52 
However, researchers have recommended that 
patients should not take vitamin E to treat AD without 
the supervision of a physician, as in high doses it can 
interact negatively with other medications, including 
those prescribed to lower cholesterol.
human immunodeficiency virus 
and acquired immunodeficiency 
syndrome
Vitamin E is an important anti-inflammatory 
agent that is often found to be deficient in human 
immunodeficiency virus (HIV)-positive individuals; 
however, it is not known whether vitamin E 
supplementation is beneficial either at every or any 
stage of  HIV infection. At a dose of 400 IU, vitamin 
E was shown to restore delayed skin hypersensitivity 
reactions and interleukin-2 production, and at high 
doses it was shown to stimulate T helper cell (CD4 
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or acquired condition that impairs their ability to 
absorb the vitamin (for instance, cystic fibrosis, short 
bowel syndrome or bile duct obstruction) and in those 
who cannot absorb dietary fat or have rare disorders 
of fat metabolism. Recent reports have shown that the 
alpha-TTP regulates the secretion of alpha-tocopherol 
from the liver cells and that missense mutations of 
some arginine residues at the surface of the alpha-
TTP can cause severe vitamin E deficiency in 
humans.63 The wild-type alpha-TTP was found to bind 
phosphatidylinositol phosphates (PIPs), whereas the 
arginine mutants did not—where the PIPs in the target 
membrane promoted the inter-membrane transfer 
of alpha-tocopherol by alpha-TTP. The resulting 
symptoms of vitamin E deficiency include muscle 
weakness, vision problems, immune system changes, 
numbness, difficulty in walking and tremors as well as 
a poor sense of balance. Apart from these symptoms, 
deficiency can also lead to neuromuscular problems 
such as spinocerebellar ataxia and myopathies,24 
dysarthria, an absence of deep tendon reflexes, the 
loss of both vibratory sensations and positive Babinski 
reflexes.24 Vitamin E deficiency can also cause anaemia 
due to the oxidative damage to the red blood cells,24 
retinopathy64–67 and the impairment of the immune 
response.59–61 If untreated, vitamin E deficiency may 
result in blindness, heart disease, permanent nerve 
damage and impaired thinking. Some reports also 
suggest that vitamin E deficiency can even result in 
male infertility.24
Conclusion
Vitamin E was first used as a supplement in Canada by 
the physicians Shute and Shute; based on the positive 
results it achieved, they began using it regularly in their 
practices. Since then, well-designed experimental and 
clinical studies have progressed steadily and increased 
our knowledge of vitamin E. The antioxidative 
properties of vitamin E have been found to play a 
vital role in the battle against various diseases such as 
atherosclerosis, oxidative stress, cancer, cataract and 
AD, among others. 
This review focussed on the important functions 
of vitamin E in some diseases; in addition to these, this 
vitamin has been found to be effective against asthma, 
allergies and diabetes, among others. Discussion 
of the dietary sources, RDA and the interaction of 
vitamin E supplements with other dietary factors, has 
demonstrated the need for and significance of vitamin 
E in the human context. Thus, raising public awareness 
of the role of dietary antioxidants in maintaining better 
health would benefit a number of lives. 
T-cell) proliferation.53 In 1997, Tang et al. studied the 
association between serum vitamin A and E levels with 
HIV-1 disease progression. In this study, it was found 
that men with serum vitamin E levels above 23.5 µm/L 
had a significantly reduced risk of disease progression. 
A strong correlation was noted in this cohort between 
the intake of supplements containing vitamin E at the 
point of entry into the study and high blood levels of 
vitamin E.54
A study on murine acquired immunodeficiency 
syndrome (AIDS) using a 15-fold increase in dietary 
vitamin E showed the normalisation of immune 
parameters that are altered in HIV/AIDS.55 Apart 
from this, an increase in dietary vitamin E has also 
been shown to protect against the side-effects of 
azidothymidine, such as bone marrow toxicity.56 Related 
studies on bone marrow cultures from stage IV AIDS 
patients using d-alpha-tocopherol supplementation 
revealed similar results.57 Nevertheless, it has also been 
reported that higher vitamin E levels pre-infection 
were found to be associated with increased mortality. 
Thus, further research is needed to elucidate the role 
vitamin E plays in the pathogenesis of HIV-1.58
immunity
It has now been proven that vitamin E stimulates the 
body’s defences, enhances humoral and cell immune 
responses and increases phagocytic functions. It has 
a pronounced effect in infectious diseases where 
immune phagocytosis is involved, but is less effective 
in the case of cell-mediated immune defences. Its 
supplementation significantly enhances both cell-
mediated and humoral immune functions in humans, 
especially in the elderly. A daily intake of 200 mg of 
vitamin E improved the antibody response to various 
vaccines in healthy subjects who showed no adverse 
side-effects to vitamin E supplementation.59 Vitamin 
E also enhanced resistance to viral diseases in elderly 
subjects, where higher plasma vitamin E levels 
correlated with a reduced number of infections over 
a three-year period.60 A recent study by Kutty et al. 
showed that a daily supplementation of vitamin E can 
enhance the immune response to a specific antigen.61
Besides the above mentioned diseases, vitamin E 
has also been found to play a beneficial role in other 
diseases, such as photodermatitis, menstrual pain/
dysmenorrhoea, pre-eclampsia and tardive dyskinesia, 
when taken along with vitamin C.62 
Vitamin E Deficiency
Vitamin E deficiency is quite rare in humans. It 
happens almost exclusively in people with an inherited 
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Apart from the enormous benefits reported, there 
has always been debate about the exact function of 
vitamin E and its role in various diseases. There are 
many conflicting reports of positive and negative 
results on the same biological activities in the 
literature. The primary hindrance in determining 
the roles of vitamin E in human health is the lack 
of validated biomarkers for vitamin E intake and 
status, which would help to relate intakes to possible 
clinical outcomes. In conclusion, although the data 
surrounding vitamin E is contradictory, the current 
literature appears to support the view that the benefits 
outweigh the side-effects.
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